Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

D S Bakker, M M van der Wal, L E M Heeb, B Giovannone, M Asamoah, E M Delemarre, J Drylewicz, S Nierkens, O Boyman, M S de Bruin-Weller, J L Thijs, F van Wijk

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Abstract

Dupilumab, a mAb targeting IL-4 receptor alpha (IL-4Rα), markedly improves disease severity in patients with atopic dermatitis. However, the effect of IL-4Rα blockade on dynamics of circulating skin-homing T cells, which are crucial players in the pathologic mechanism of atopic dermatitis, has not been studied yet. In addition, it remains unknown whether dupilumab treatment induces long-lasting T- and B-cell polarization. Therefore, we studied the short- and long-term effects of dupilumab treatment on IL-4Rα expression and T-cell cytokine production within total and skin-homing (cutaneous lymphocyte antigen +/CCR4 +) subpopulations in patients with moderate-to-severe atopic dermatitis. Dupilumab treatment completely blocked IL-4Rα expression and signal transducer and activator of transcription 6 phosphorylation in CD19 + B cells and CD4 + T cells within 2 hours of administration and through week 52. Although no change in the proportion of skin-homing T-cell subsets was found, dupilumab treatment significantly decreased the percentage of proliferating (Ki67 +) and T helper type 2 and T helper type 22 cytokine-producing skin-homing CD4 + T cells at week 4. No evidence of general T helper type cell skewing following a year of dupilumab treatment was found. In summary, dupilumab treatment rapidly and stably inhibited IL-4Rα, which was accompanied by a strong early functional immunological effect specifically on skin-homing T cells without affecting overall T helper type cell skewing in the long term.

Original languageEnglish
Pages (from-to)1943-1953.e13
JournalJournal of Investigative Dermatology
Volume141
Issue number8
Early online date18 Feb 2021
DOIs
Publication statusPublished - Aug 2021

Fingerprint

Dive into the research topics of 'Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis'. Together they form a unique fingerprint.

Cite this